Merkel Cell Carcinoma

You are at the center of everything we do at Fred Hutchinson Cancer Center. Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.

We guide you every step of the way, combining our deep clinical expertise in Merkel cell carcinoma (MCC) with a commitment to meet your unique needs.

Why Choose Fred Hutch?

World-Renown Merkel Cell Carcinoma Experts

We have one of the most active MCC clinical and research programs in the world, led by Paul Nghiem, MD. Dr. Nghiem is a dermatologist and scientist at the forefront of MCC care. Our team of experts also includes surgeons, medical oncologists and radiation oncologists at our Multidisciplinary Skin Oncology Clinic.

Merkel Cell Carcinoma-Specialized Surgeons

Our skin cancer surgeon team includes experts in surgical oncology, reconstruction and head and neck surgery. This team specializes in the treatment of MCC, and you can feel confident knowing that the surgeon who cares for you is best-suited for your specific diagnosis.

Where You’re Treated First Matters Most

Studies have shown that patients evaluated and treated at a multidisciplinary cancer center, like Fred Hutch, have better outcomes — and that the first treatment you receive for cancer is by far the most important. Patients who begin treatment at Fred Hutch often have better outcomes than those who started treatment elsewhere.

A National Leader in Cancer Care

Fred Hutch is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.

NCI Comprehensive Cancer Center

We are a comprehensive cancer center, a designation from the National Cancer Institute (NCI) that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.

Learn About Merkel Cell Carcinoma

MCC is a rare and aggressive form of skin cancer. A quick diagnosis and appropriate treatment are essential to cure this disease. Fred Hutch offers comprehensive treatment from a team of experts who specialize in MCC.

Facts & Resources

Merkel Cell Carcinoma Treatment

Our experienced doctors are well known for providing innovative Merkel cell carcinoma treatments, including immunotherapy, vaccine protocols and gene therapy as well as surgery, radiation therapy and chemotherapy. 


Merkel Cell Carcinoma Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. 

Care Team

Latest Treatments and Clinical Trials

We unite the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in MCC clinical studies not available everywhere. Fred Hutch was a leading clinical trial site for avelumab (Bavencio), the first treatment approved by the U.S. Food and Drug Administration for metastatic MCC.

Many patients at Fred Hutchinson Cancer Center receive promising therapies by taking part in clinical trials. These research studies are done by physician-scientists from Fred Hutch and UW Medicine. They test new treatments or new ways to use current treatments.

Every advance in cancer treatment in recent years has come out of clinical trials. We offer more active clinical trials than anywhere else, which means more treatment options for patients like you.

For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at both Fred Hutch and UW Medicine is one reason many patients come to us for care.

Related News

All news
Six researchers receive $3.5 million in grants from Kuni Foundation Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care February 27, 2023
Merkel cell carcinoma researcher Dr. Nick Salisbury named Brave Fellow Rare skin cancer is focus of work by Fred Hutch scientist who will receive support honoring runner Gabe Grunewald October 6, 2022
Dr. Denise Galloway elected Fellow of the American Association for Cancer Research Academy Cancer biologist contributed basic and translational insights that made the cancer-preventive HPV vaccine possible March 22, 2022